ICON Cash on Hand 2012-2025 | ICLR
ICON cash on hand from 2012 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
- ICON cash on hand for the quarter ending September 30, 2025 was $0.469B, a 32.58% decline year-over-year.
- ICON cash on hand for 2024 was $0.539B, a 41.76% increase from 2023.
- ICON cash on hand for 2023 was $0.38B, a 30.84% increase from 2022.
- ICON cash on hand for 2022 was $0.29B, a 61.47% decline from 2021.
|
ICON Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $539 |
| 2023 | $380 |
| 2022 | $290 |
| 2021 | $754 |
| 2020 | $842 |
| 2019 | $570 |
| 2018 | $456 |
| 2017 | $360 |
| 2016 | $261 |
| 2015 | $190 |
| 2014 | $216 |
| 2013 | $321 |
| 2012 | $190 |
| 2011 | $174 |
|
ICON Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-09-30 | $469 |
| 2025-06-30 | $390 |
| 2025-03-31 | $527 |
| 2024-12-31 | $539 |
| 2024-09-30 | $696 |
| 2024-06-30 | $507 |
| 2024-03-31 | $398 |
| 2023-12-31 | $380 |
| 2023-09-30 | $315 |
| 2023-06-30 | $272 |
| 2023-03-31 | $282 |
| 2022-12-31 | $290 |
| 2022-09-30 | $611 |
| 2022-06-30 | $617 |
| 2022-03-31 | $561 |
| 2021-12-31 | $754 |
| 2021-09-30 | $1,010 |
| 2021-06-30 | $1,057 |
| 2021-03-31 | $944 |
| 2020-12-31 | $842 |
| 2020-09-30 | $710 |
| 2020-06-30 | $594 |
| 2020-03-31 | $484 |
| 2019-12-31 | $570 |
| 2019-09-30 | $471 |
| 2019-06-30 | $431 |
| 2019-03-31 | $478 |
| 2018-12-31 | $456 |
| 2018-09-30 | $491 |
| 2018-06-30 | $373 |
| 2018-03-31 | $354 |
| 2017-12-31 | $360 |
| 2017-09-30 | $292 |
| 2017-06-30 | $315 |
| 2017-03-31 | $319 |
| 2016-12-31 | $261 |
| 2016-09-30 | $304 |
| 2016-06-30 | $251 |
| 2016-03-31 | $248 |
| 2015-12-31 | $190 |
| 2015-09-30 | $317 |
| 2015-06-30 | $192 |
| 2015-03-31 | $192 |
| 2014-12-31 | $216 |
| 2014-09-30 | $249 |
| 2014-06-30 | $175 |
| 2014-03-31 | $364 |
| 2013-12-31 | $321 |
| 2013-09-30 | $219 |
| 2013-06-30 | $184 |
| 2013-03-31 | $200 |
| 2012-12-31 | $190 |
| 2012-09-30 | $180 |
| 2012-06-30 | $168 |
| 2012-03-31 | $206 |
| 2011-12-31 | $174 |
| 2011-09-30 | $166 |
| 2011-06-30 | $216 |
| 2011-03-31 | $232 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.747B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.691B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Elevance Health (ELV) | United States | $83.311B | 12.22 |
| Cencora (COR) | United States | $68.839B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.83 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |